Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

2013 trends

- PMLiVE

Teva’s migraine injection approved in Europe

Third anti-CGRP treatment to hit the market

- PMLiVE

Janssen’s CAR-T gains PRIME status in Europe

EMA fast-track could help Janssen close gap

- PMLiVE

Synergy Worldwide opens New York office

The move is part of its business growth strategy

- PMLiVE

AVEO warns EU approval of Fotivda could be at risk

Concerns arose with overall survival data

- PMLiVE

Biogen’s Spinraza overpriced, says ICER

Cost watchdog warns high price puts pressure on US health system

- PMLiVE

Pfizer gets EU nod for Tagrisso rival Vizimpro

Five year survival still only 12%

What role for pharma in helping to deliver integrated care?

Steve How and Paul Midgley, of Wilmington Healthcare, explore how pharma can support local health economies in providing joined-up, holistic services

Wilmington Healthcare

Novartis day

Novartis claims first place for psoriasis drug Cosentyx in China

Trial data from China helped support filing

- PMLiVE

Avenir Global acquires UK communications firm Hanover

Avenir says it aims to build a “powerhouse of specialist communications firms”

- PMLiVE

Health Unlimited’s specialist consultancy expands to the UK

And appoints Claire Hoffman as Director

- PMLiVE

Autolus’ next-gen CAR-T looks promising in ALL

Safety profile could bring greater market potential

- PMLiVE

Gottlieb signs off with flair – and pledge of further drug price commentary

Highlights issues of insulin prices and competition

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links